Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P T Pollak

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|March 12, 1999
Elevation of high-density lipoprotein cholesterol in humans during long-term therapy with amiodaroneP T Pollak, M H Tan
The Annals of Pharmacotherapy|January 1, 1997
Hazards of doubling phenytoin dose in the face of an unrecognized interaction with ciprofloxacinP T Pollak, K L Slayter
The Annals of Pharmacotherapy|January 7, 1998
Comment: ciprofloxacin-phenytoin interactionP T Pollak, K L Slayter
Pharmacotherapy|July 1, 1997
Reduced serum theophylline concentrations after discontinuation of azithromycin: evidence for an unusual interactionP T Pollak, K L Slayter
Archives of Internal Medicine|February 4, 1998
Amrinone and amiodarone: serious confusion in the intravenous lineP T Pollak, S Pierce, C Cooke
Clinical Pharmacology and Therapeutics|June 29, 2000
Population pharmacokinetics of long-term oral amiodarone therapyP T Pollak, T Bouillon, S L Shafer
Pharmacotherapy|December 17, 1998
Clinical efficacy of amiodaroneP E Nolan, J Nappi, P T Pollak
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administrationP K Yeung, S J Mosher, P T Pollak
British Journal of Clinical Pharmacology|August 1, 1993
Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentrationP T Pollak, A D Sharma, S G Carruthers
Clinical and Translational Science|February 25, 2017
Therapeutic Differences in 24-h Ambulatory Blood Pressures in Patients Switched Between Bioequivalent Nifedipine Osmotic Systems With Differing Delivery TechnologiesP T Pollak, R J Herman, R D Feldman
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|March 12, 1999
Elevation of high-density lipoprotein cholesterol in humans during long-term therapy with amiodaroneP T Pollak, M H Tan
The Annals of Pharmacotherapy|January 1, 1997
Hazards of doubling phenytoin dose in the face of an unrecognized interaction with ciprofloxacinP T Pollak, K L Slayter
The Annals of Pharmacotherapy|January 7, 1998
Comment: ciprofloxacin-phenytoin interactionP T Pollak, K L Slayter
Pharmacotherapy|July 1, 1997
Reduced serum theophylline concentrations after discontinuation of azithromycin: evidence for an unusual interactionP T Pollak, K L Slayter
Archives of Internal Medicine|February 4, 1998
Amrinone and amiodarone: serious confusion in the intravenous lineP T Pollak, S Pierce, C Cooke
Clinical Pharmacology and Therapeutics|June 29, 2000
Population pharmacokinetics of long-term oral amiodarone therapyP T Pollak, T Bouillon, S L Shafer
Pharmacotherapy|December 17, 1998
Clinical efficacy of amiodaroneP E Nolan, J Nappi, P T Pollak
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administrationP K Yeung, S J Mosher, P T Pollak
British Journal of Clinical Pharmacology|August 1, 1993
Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentrationP T Pollak, A D Sharma, S G Carruthers
Clinical and Translational Science|February 25, 2017
Therapeutic Differences in 24-h Ambulatory Blood Pressures in Patients Switched Between Bioequivalent Nifedipine Osmotic Systems With Differing Delivery TechnologiesP T Pollak, R J Herman, R D Feldman
Pageof 5